< Registro CFI | Products | Beclometasone/Formoterolo
Beclometasone/Formoterolo
Products

Beclometasone/Formoterolo

Carbon footprint registration
P-2019-0008
Product description
Beclometasone/Formoterol 100/6 micrograms pressurized solution for inhalation 120 puffs, produced by Chiesi Farmaceutici
Registration of
25/11/2022
Reference year
2019
Verification body
Certiquality
Reference PCR
PCR Basic Module for CPC Division 35
CFP study report and version
CFP Study report generale e specifico_dati 2019 – rev.1 del 28/07/2020
CFP (g CO₂e/UD)
93.74
Declared/functional unit
1 actuation
System boundaries
From cradle to grave
Excluded phases
none
Production plants included
Via San Leonardo 96 a Parma
Notes
n.a.

93.74 g CO₂e/UD

Beclometasone/Formoterolo
Download certificate (52.7 KB)
Chiesi Farmaceutici S.p.A.
Company name
Chiesi Farmaceutici S.p.A.
Website
https://www.chiesi.com
Contacts
Andrea Volpato, Rossella Ferri
Address
Via Palermo 26/A - 43122 Parma - Italy
Phone number
+39 0521 2791

Carbon footprint of Product

GHG values
GHG values (g CO₂e/UD)
GHG values
Net fossil GHG emissions and removals
CFP values
93,9
GHG values
Biogenic GHG emissions and removals
CFP values
-0,148
GHG values
GHG emissions and removals resulting from dLUC
CFP values
0,00847
GHG values
Aircraft GHG emissions
CFP values
0,205